James A Harper - Net Worth and Insider Trading

James A Harper Net Worth

The estimated net worth of James A Harper is at least $566,200 dollars as of 2024-11-10. James A Harper is the Director of Corcept Therapeutics Inc and owns about 9,500 shares of Corcept Therapeutics Inc (CORT) stock worth over $566,200. Details can be seen in James A Harper's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James A Harper has not made any transactions after 2006-07-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of James A Harper

To

James A Harper Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James A Harper owns 1 companies in total, including Corcept Therapeutics Inc (CORT) .

Click here to see the complete history of James A Harper’s form 4 insider trades.

Insider Ownership Summary of James A Harper

Ticker Comapny Transaction Date Type of Owner
CORT Corcept Therapeutics Inc 2006-07-05 director

James A Harper Latest Holdings Summary

James A Harper currently owns a total of 1 stock. James A Harper owns 9,500 shares of Corcept Therapeutics Inc (CORT) as of July 5, 2006, with a value of $566,200.

Latest Holdings of James A Harper

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CORT Corcept Therapeutics Inc 2006-07-05 9,500 59.60 566,200

Holding Weightings of James A Harper


James A Harper Form 4 Trading Tracker

According to the SEC Form 4 filings, James A Harper has made a total of 0 transactions in Corcept Therapeutics Inc (CORT) over the past 5 years. The most-recent trade in Corcept Therapeutics Inc is the acquisition of 2,400 shares on July 5, 2006, which cost James A Harper around $9,912.

Insider Trading History of James A Harper

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James A Harper Trading Performance

GuruFocus tracks the stock performance after each of James A Harper's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James A Harper is -15.26%. GuruFocus also compares James A Harper's trading performance to market benchmark return within the same time period. The performance of stocks bought by James A Harper within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how James A Harper's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of James A Harper

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.53 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 7.13 LIMIT LIMIT LIMIT LIMIT LIMIT

James A Harper Ownership Network

Ownership Network List of James A Harper

No Data

Ownership Network Relation of James A Harper

Insider Network Chart

James A Harper Owned Company Details

What does Corcept Therapeutics Inc do?

Who are the key executives at Corcept Therapeutics Inc?

James A Harper is the director of Corcept Therapeutics Inc. Other key executives at Corcept Therapeutics Inc include Chief Development Officer William Guyer , CHIEF FINANCIAL OFFICER Gary Charles Robb , and Chief Accounting Officer Joseph Douglas Lyon .

Corcept Therapeutics Inc (CORT) Insider Trades Summary

Over the past 18 months, James A Harper made no insider transaction in Corcept Therapeutics Inc (CORT). Other recent insider transactions involving Corcept Therapeutics Inc (CORT) include a net sale of 70,000 shares made by Joseph Douglas Lyon , a net sale of 28,750 shares made by Swisher Daniel N Jr , and a net sale of 225,000 shares made by Sean Maduck .

In summary, during the past 3 months, insiders sold 44,101 shares of Corcept Therapeutics Inc (CORT) in total and bought 0 shares, with a net sale of 44,101 shares. During the past 18 months, 517,899 shares of Corcept Therapeutics Inc (CORT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 517,899 shares.

Corcept Therapeutics Inc (CORT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Corcept Therapeutics Inc Insider Transactions

No Available Data

James A Harper Mailing Address

Above is the net worth, insider trading, and ownership report for James A Harper. You might contact James A Harper via mailing address: 11158 Parkside Crescent, Carmel In 46032.